Literature DB >> 23400421

The first Insubria autumn school on neuroimmunopharmacology: challenging paradigms beyond boundaries.

Marco Cosentino1, Howard E Gendelman.   

Abstract

This issue of the Journal of Neuroimmune Pharmacology is dedicated, in part, to the proceedings of the First Insubria Autumn School on Neuroimmunopharmacology, organized by Marco Cosentino, Georges J.M. Maestroni, Franca Marino (University of Insubria, Varese, Italy), Manfred Schedlowsky (University of Duisburg-Essen, Germany) and Rainer H. Straub (University of Regensburg, Germany), which took place in November 2011 in Varese, Italy. The School was attended by 50 graduate students and postdoctoral fellows in medical and biological disciplines from 16 european universities and 25 faculties/departments.

Entities:  

Mesh：

Year:  2013        PMID： 23400421     DOI： 10.1007/s11481-013-9440-1

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN： 1557-1890            Impact factor:   4.147


  14 in total

1.  Neuroinflammation and cognitive dysfunction in chronic disease and aging.

Authors:  Amy M Hein; M Kerry O'Banion
Journal:  J Neuroimmune Pharmacol       Date:  2012-01-18       Impact factor: 4.147

2.  Amygdaloid signature of peripheral immune activation by bacterial lipopolysaccharide or staphylococcal enterotoxin B.

Authors:  Geraldine Prager; Martin Hadamitzky; Andrea Engler; Raphael Doenlen; Timo Wirth; Gustavo Pacheco-López; Ute Krügel; Manfred Schedlowski; Harald Engler
Journal:  J Neuroimmune Pharmacol       Date:  2012-05-27       Impact factor: 4.147

3.  Education Mission for Neuroimmune Pharmacology

Authors:  Sulie L Chang; Guy A Cabral
Journal:  J Neuroimmune Pharmacol       Date:  2011-01-07       Impact factor: 4.147

4.  Drugs of abuse effects on immunity and microbial pathogenesis.

Authors:  Sabita Roy
Journal:  J Neuroimmune Pharmacol       Date:  2011-10-14       Impact factor: 4.147

Review 5.  Adequate antigen availability: a key issue for novel approaches to tumor vaccination and tumor immunotherapy.

Authors:  Roberto S Accolla; Giovanna Tosi
Journal:  J Neuroimmune Pharmacol       Date:  2012-12-07       Impact factor: 4.147

Review 6.  Cytokine modulation is necessary for efficacious treatment of experimental neuropathic pain.

Authors:  Paola Sacerdote; Silvia Franchi; Sarah Moretti; Mara Castelli; Patrizia Procacci; Valerio Magnaghi; Alberto E Panerai
Journal:  J Neuroimmune Pharmacol       Date:  2012-12-16       Impact factor: 4.147

Review 7.  Neuroimmunology of the atherosclerotic plaque: a morphological approach.

Authors:  Rita Businaro
Journal:  J Neuroimmune Pharmacol       Date:  2012-11-14       Impact factor: 4.147

Review 8.  Neural and immune mechanisms in the pathogenesis of Parkinson's disease.

Authors:  Fabio Blandini
Journal:  J Neuroimmune Pharmacol       Date:  2013-02-03       Impact factor: 4.147

Review 9.  Learned immunosuppression: extinction, renewal, and the challenge of reconsolidation.

Authors:  Martin Hadamitzky; Harald Engler; Manfred Schedlowski
Journal:  J Neuroimmune Pharmacol       Date:  2012-07-13       Impact factor: 4.147

10.  Viral infections of the central nervous system: pathogenesis to therapeutics.

Authors:  Samantha S Soldan; Steven Jacobson
Journal:  J Neuroimmune Pharmacol       Date:  2010-07-24       Impact factor: 4.147
View more
  2 in total

1.  The Second Insubria Autumn School on Neuroimmune Pharmacology: Repurposing Established Drugs for Novel Indications.

Authors:  Marco Cosentino; Franca Marino
Journal:  J Neuroimmune Pharmacol       Date:  2015-12-16       Impact factor: 4.147

Review 2.  Bridge between neuroimmunity and traumatic brain injury.

Authors:  Matthew L Kelso; Howard E Gendelman
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.